Carsten Wrenger

1374 Prof. Lineu Prestes Avenue
Sao Paulo, SP 05508000, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 82 publications

Revisiting Glutathione Transferases of Plasmodium as Potential Targets for Coadjuvant Therapies and the Development of New Antimalarials.

Revisiting Glutathione Transferases of Plasmodium as Potential Targets for Coadjuvant Therapies and the Development of New Antimalarials.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: June 23, 2026

Molecular Characterization of Calu-3 Cells from Submerged to Air-Liquid Interface to Model Lung Infections.

Molecular Characterization of Calu-3 Cells from Submerged to Air-Liquid Interface to Model Lung Infections.

Journal: Journal of proteome research

Published: January 28, 2026

Adjuvant combination and antigen multimerization shape neutralizing antibody and T cell responses to a SARS-CoV-2 RBD subunit vaccine.

Adjuvant combination and antigen multimerization shape neutralizing antibody and T cell responses to a SARS-CoV-2 RBD subunit vaccine.

Journal: Frontiers in immunology

Published: April 12, 2025

Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variants.

Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variants.

Journal: Virology

Published: March 20, 2025

West Nile virus - a re-emerging global threat: recent advances in vaccines and drug discovery.

West Nile virus - a re-emerging global threat: recent advances in vaccines and drug discovery.

Journal: Frontiers in cellular and infection microbiology

Published: January 28, 2025

Exploring Aspartate Transcarbamoylase: A Promising Broad-Spectrum Target for Drug Development.

Exploring Aspartate Transcarbamoylase: A Promising Broad-Spectrum Target for Drug Development.

Journal: Chembiochem : a European journal of chemical biology

Published: December 09, 2024

P.1 and P.2 SARS-CoV-2 Brazilian variants activate the unfolded protein response with a time and pathway specificity.

P.1 and P.2 SARS-CoV-2 Brazilian variants activate the unfolded protein response with a time and pathway specificity.

Journal: Journal of proteomics

Published: August 15, 2024

Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19.

Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19.

Journal: Frontiers in pharmacology

Published: April 08, 2024

High Target Homology Does Not Guarantee Inhibition: Aminothiazoles Emerge as Inhibitors of Plasmodium falciparum.

High Target Homology Does Not Guarantee Inhibition: Aminothiazoles Emerge as Inhibitors of Plasmodium falciparum.

Journal: ACS infectious diseases

Published: February 17, 2024

Enhanced Immunogenicity and Protective Effects against SARS-CoV-2 Following Immunization with a Recombinant RBD-IgG Chimeric Protein.

Enhanced Immunogenicity and Protective Effects against SARS-CoV-2 Following Immunization with a Recombinant RBD-IgG Chimeric Protein.

Journal: Vaccines

Published: January 24, 2024

Structure and dynamics of the staphylococcal pyridoxal 5-phosphate synthase complex reveal transient interactions at the enzyme interface.

Structure and dynamics of the staphylococcal pyridoxal 5-phosphate synthase complex reveal transient interactions at the enzyme interface.

Journal: The Journal of biological chemistry

Published: October 31, 2023

1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors.

1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors.

Journal: Scientific reports

Published: August 17, 2023

Showing 1-12 of 82

Last Updated: 09/26/2026